NTRK2 and Alzheimer disease: BDNF signaling was also shown to be altered in AD as an splicing form of TrKB, which gives rise to a truncated form of the receptor lacking the tyrosine kinase domain (presumably acting as a dominant negative), is expressed predominantly in hippocampus and frontal cortex in AD [23].